| Names | |
|---|---|
| IUPAC name
4-[[(4-Chlorophenyl)-(3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]butanoic acid
| |
| Other names
Progabide acid; LS-187121; SL-75-102-00
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C17H15ClFNO3 | |
| Molar mass | 335.76 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Progabide acid, also known as SL-75.102, is a GABA receptor agonist and an active metabolite of the anticonvulsant drug progabide.[1][2][3]
References
[edit]- ^ Bergmann KJ (1985). "Progabide: a new GABA-mimetic agent in clinical use". Clin Neuropharmacol. 8 (1): 13–26. doi:10.1097/00002826-198503000-00002. PMID 2983890.
- ^ Hamberger, C.; Barre, J.; Brandebourger, M.; Urien, S.; Taiclet, A.; Thenot, J. P.; Tillement, J. P. (April 1987). "Progabide and SL 75102 binding to plasma proteins and red blood cells in humans". Int J Clin Pharmacol Ther Toxicol. 25 (4): 178–184. PMID 3583466.
- ^ Kubová, H.; Haugvicová, R.; Mares, P. (1997). "Anticonvulsant effect of SL 75 102 in adult and immature rats". Physiol Res. 46 (1): 73–76. PMID 9728525.
